Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Quantitative Reverse Transcription Polymerase Chain Reaction
43%
Immunoglobulin E
33%
Immunotherapy
33%
Tumor Antigen
33%
Chimeric Antigen Receptor T-Cell
33%
RNA Extraction
26%
Virus
21%
Xenograft
13%
Viral Load
13%
Real-Time Polymerase Chain Reaction
13%
DNA Virus
13%
DNA RNA Hybridization
13%
Monoclonal Antibody
13%
Reverse Transcription Polymerase Chain Reaction
8%
COVID-19
8%
Nose
8%
RNA Binding
8%
Type I Hypersensitivity
6%
Effector Cell
6%
Chimeric Antigen Receptor T-Cell Therapy
6%
Graft-Versus-Host Disease
6%
CRISPR/Cas9
6%
Basophil Activation
6%
Immunoglobulin E Antibody
6%
Cytotoxicity
6%
Cytokine Release Syndrome
6%
Cell Surface
6%
Overall Survival
6%
Cancer Immunotherapy
6%
Interferon Gamma
6%
Heat Treatment
6%
Cancer Cell
6%
Interleukin 2
6%
Tumor Cell
6%
Intravenous Immunoglobulin
6%
Bioinformatics
6%
Medicine and Dentistry
Severe Acute Respiratory Syndrome Coronavirus 2
66%
Quantitative Reverse Transcription Polymerase Chain Reaction
26%
Plaque Assay
13%
Virus RNA
13%
Nucleic Acid Analysis
13%
Nasopharyngeal Swab
13%
Virus DNA
13%
Real-Time Polymerase Chain Reaction
13%
DNA RNA Hybridization
13%
Virus
13%
Pharmacology, Toxicology and Pharmaceutical Science
Nucleic Acid
33%
SARS Coronavirus
33%
2 Propanol
8%
Silicon Dioxide
8%
Virus RNA
8%
Sodium Dodecyl Sulfate
8%
Infection
8%
Table Salt
8%
